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Objective: To present recommendations for the cleansing,
debridement, dressing, and monitoring of acute skin trauma in
patients.
Background: Acute skin trauma is common during partic-
ipation in athletic and recreational activities. Clinical decisions
and intervention protocols after injury vary among athletic
trainers and are often based on ritualistic practices. An
understanding of cleansing, debridement, and dressing tech-
niques; clinical features of infection and adverse reactions; and
monitoring of acute skin trauma is critical for certified athletic
trainers and other allied health and medical professionals to
create a local wound environment that promotes healing and
lessens the risk of complications.
Recommendations: These guidelines are intended to
provide the certified athletic trainer and others participating in
athletic health care with specific knowledge about and recom-
mendations for the management of acute skin trauma.
Key Words: abrasions, avulsions, blisters, incisions, lacer-
ations, punctures, cleansing, debridement, nonocclusive dress-
ings, occlusive dressings, infection, adverse reactions
T
raumatic injury to the skin is common among
athletes participating in all sports.1 The exact
frequencies of abrasions, avulsions, blisters, inci-
sions, lacerations, and punctures are difficult to calculate
because many patients do not seek medical attention after
injury; for others, their activity level is initially unaffected,
and the injury is not recorded on surveillance reports.
Unreported skin trauma and inappropriate wound manage-
ment can result in delayed healing, cross-contamination,
bacterial colonization, and infection, adversely affecting the
overall health and playing status of the patient. Managing
acute skin trauma through appropriate cleansing, debride-
ment, and dressing techniques can create an environment
conducive to healing and lessen the risk of complications.2,3
Wound-management techniques have undergone drastic
changes over the last 50 years, and other allied health care
professions, organizations, and facilities have developed
guidelines that serve as standards of care.4–6 However,
guidelines for the management of acute skin trauma by
athletic trainers (ATs) are limited in the literature.1,7 The
development and implementation of cleansing, debride-
ment, and dressing techniques for acute skin trauma are
critical for ATs to successfully deliver health care services
to patients. The following review and recommendations
provide information on the management of acute skin
trauma and guidelines for ATs and other allied health and
medical professionals who care for patients.
RECOMMENDATIONS
This position statement is based on current research and
literature with regard to the cleansing, debridement,
dressing, and monitoring of acute skin trauma. We
independently categorized the studies and literature using
the Strength of Recommendation Taxonomy (SORT)
developed by the American Academy of Family Physi-
cians.8 The taxonomy grades the quality of the data from
the literature (level of evidence) and provides strength
ratings for the suggested recommendations with the letter
A, B, or C (Table 1).
The recommendations have been organized into the
following categories: wound cleansing, debridement, dress-
ings, identification of infection and adverse reactions,
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follow-up, and supplies for athletic training facilities and
kits.
Cleansing
1. The wound bed and adjacent periwound tissues should be
thoroughly cleansed as soon as possible after acute skin
trauma.9–11 Strength of recommendation: C
2. After initial cleansing, the wound should be cleansed only
when clinically necessary (eg, visibly contaminated,
clinically infected).9,12–18 Strength of recommendation: C
3. Irrigation can be used to cleanse superficial- to full-
thickness abrasions, incisions, and lacerations.19,20
Strength of recommendation: B
a. To effectively remove wound debris, irrigation
pressure should range between 4 and 15 pounds per
square inch (psi; 27.58–103.42 kPa).11,19,21–23 Strength
of recommendation: B
b. A range of 7 to 11 psi (48.26–75.84 kPa) can be
achieved with a 35-mL syringe and an 18- to 20-gauge
needle, needle hub, or plastic cannula.11,19,23,24
Strength of recommendation: B
4. Showering can be used to cleanse postoperative inci-
sions.19,20,25 Strength of recommendation: A
5. Hydrotherapy (eg, whirlpool baths and soaks) may be
used during cleansing to hydrate a wound.11,24,26 Strength
of recommendation: C
6. Scrubbing or swabbing of the wound bed should be
avoided because it may be ineffective in reducing
bacterial counts and can further contaminate and damage
the granulation tissue.9,13,24,26–29 Strength of recommen-
dation: C
7. Normal saline and potable tap water should be used as
cleansing agents with superficial- to full-thickness
abrasions, incisions, and lacerations.19,20,25,30–33 Strength
of recommendation: A
8. Tap water should be avoided in the presence of exposed
bone or tendon, although the basis for this guideline is
unclear.34 Strength of recommendation: C
9. Antiseptics (eg, povidone-iodine, hydrogen peroxide)
should be used with caution as cleansing agents because
some may be toxic to tissues.19,35–43 Strength of
recommendation: B
10. Irrigation with 1% povidone-iodine can be used to cleanse
acute, traumatic, contaminated wounds.19 Strength of
recommendation: B
11. The cleansing solution should be delivered to the wound
at a temperature between 98.68F and 107.68F (378C and
428C).13,14,44,45 Strength of recommendation: C
Debridement
12. The area of acute skin trauma should be thoroughly
cleansed and debrided before dressings are applied.4,46–53
Strength of recommendation: B
13. Debridement should continue until well-vascularized,
healthy granulation or epithelial tissue is exposed.54
Strength of recommendation: C
14. The method of debridement should be based on the type
of wound, amount and type of debris, training and
expertise of the health care provider, and cost-effective-
ness and time-effectiveness of the technique.55,56 Strength
of recommendation: C
15. Irrigation can serve as an extension of cleansing for
debridement of superficial- to full-thickness abrasions,
avulsions, blisters, incisions, lacerations, and punc-
tures.3,57–59 Strength of recommendation: C
a. Irrigation pressure should range between 4 and 15 psi
(27.58–103.4 kPa).3,57,59–61 Strength of recommenda-
tion: C
b. To avoid driving debris and contaminants deeper into
puncture wounds, an irrigation pressure of 2 to 4 psi
(13.79–27.58 kPa) should be used.3,57,59–61 Strength of
recommendation: C
16. Hydrotherapy debridement (eg, whirlpool baths and
soaks) should be avoided because it presents a risk of
cross-contamination and is neither cost-effective nor
time-effective.62,63 Strength of recommendation: C
17. Wet-to-dry debridement should be avoided because tissue
removal is nonselective and painful.54,55,57,59,64–70 Strength
of recommendation: C
18. Wet-to-moist debridement may be used for superficial- to
full-thickness abrasions, avulsions, blisters, incisions, and
lacerations and with the formation of eschar. However,
care should be taken to protect healthy granulation
tissue.59 Strength of recommendation: C
19. Scrubbing should be used only for superficial- to partial-
thickness abrasions, avulsions, blisters, incisions, and
lacerations contaminated with large quantities of small
debris (eg, sand, grass, clay, asphalt).66 Strength of
recommendation: C
20. Conservative sharp debridement can be used after
cleansing to remove loosely adhering, devitalized tissue
from superficial- to full-thickness abrasions, avulsions,
blisters, incisions, and lacerations.71,72 Strength of rec-
ommendation: C
21. Chemical debridement (eg, sodium hypochlorite, hydro-
gen peroxide, silver) should be avoided because some
elements and compounds may damage viable tis-
sue.71,73,74 Strength of recommendation: C
Table 1. Strength of Recommendation Taxonomy8a
Strength
Rating Definition
A Recommendation based on consistent and good quality
experimental evidence (morbidity, mortality, exercise and
cognitive performance, physiologic responses).
B Recommendation based on inconsistent or limited quality
experimental evidence.
C Recommendation based on consensus; usual practice;
opinion; disease-oriented evidenceb; case series or
studies of diagnosis, treatment, prevention, or screening;
or extrapolations from quasi-experimental research.
a Reprinted with permission from Ebell MH, Siwek J, Weiss BD, et
al, ‘‘Strength of Recommendation Taxonomy (SORT): A Patient-
Centered Approach to Grading Evidence in the Medical Litera-
ture,’’ February 1, 2004, Vol 69, No 3, American Family Physician
Copyright 2004 American Academy of Family Physicians. All
Rights Reserved.
b Patient-oriented evidence measures outcomes that matter to
patients: morbidity, mortality, symptoms improvement, cost reduc-
tion, and quality of life. Disease-oriented evidence measures
intermediate, physiologic, or surrogate end points that may or may
not reflect improvements in patient outcomes (eg, blood pressure,
blood chemistry, physiologic function, pathologic finding).
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22. Autolytic debridement should be used for selective
proteolytic digestion of necrotic tissue.51,55,57,58,64,71,75–85
Strength of recommendation: B
a. Autolytic debridement can be used with the following
wounds:
i. Postoperative incisions.79 Strength of recommen-
dation: B
ii. Superficial- to full-thickness abrasions, avulsions,
and lacerations. Strength of recommendation: C
iii. Superficial- to full-thickness blisters after removal
of the necrotic roof with conservative sharp
debridement.71 Strength of recommendation: C
iv. Superficial- to partial-thickness punctures.
Strength of recommendation: C
b. Autolytic debridement should be avoided with infect-
ed wounds.57,66,75 Strength of recommendation: C
Dressings
23. After thorough cleansing and debridement, an area of
acute skin trauma should be covered with an appropriate
dressing until fully healed (Table 2).2,86–90 Strength of
recommendation: B
24. Nonocclusive dressings can be used as primary dressings
with the following wounds (Table 3):
a. Woven and nonwoven gauze for clinically infected
abrasions, avulsions, blisters, incisions, lacerations, or
punctures.91,92 Strength of recommendation: C
b. Woven, nonwoven, and impregnated gauze for
puncture wounds that have cavities.93–96 Strength of
recommendation: C
c. Wound-closure strips with superficial, linear lacera-
tions and postoperative incisions under minimal static
and dynamic tension.3,97,98 Strength of recommenda-
tion: A
d. Woven gauze with superficial- to full-thickness
abrasions, avulsions, blisters, incisions, and lacera-
tions to achieve wet-to-moist debridement.55,68,91,94
Strength of recommendation: C
e. Woven and nonwoven gauze, nonadherent pads, and
adhesive strips or patches for superficial- to partial-
thickness abrasions, avulsions, and blisters and
superficial-thickness incisions, lacerations, and punc-
tures as a temporary dressing and on irregular body
surfaces.91,95,99 Strength of recommendation: C
25. Woven or nonwoven gauze, nonadherent pads, and
adhesive strips or patches can be used as secondary
dressings to absorb moderate-to-heavy exudate and
provide additional protection for superficial- to full-
thickness abrasions, avulsions, blisters, lacerations, punc-
tures, and traumatic and postoperative incisions.91,94,100,101
Strength of recommendation: C
26. Occlusive dressings should be used as primary dressings
with the following wounds (Table 4):
a. Alginates, films, foams, hydrocolloids, and hydrogels
for superficial- to partial-thickness abrasions, avul-
sions, blisters, incisions, lacerations, and punc-
tures.2,90,91,95,102–112 Strength of recommendation: A
b. Alginates, foams, and hydrocolloids for partial- to full-
thickness abrasions, avulsions, blisters, lacerations, and
traumatic and postoperative incisions.2,90,91,102,106,109–117
Strength of recommendation: A
c. Dermal adhesives for partial- to full-thickness lacer-
ations and traumatic and postoperative incisions in
areas of low skin tension.97,98,118,119 Strength of
recommendation: A
d. Alginates and foams (nonsilver or silver impregnated)
or silver-impregnated films and hydrocolloids for
contaminated and clinically infected abrasions, avul-
sions, blisters, incisions, and lacerations.91,94,120,121
Strength of recommendation: C
27. Films and hydrocolloids can be used as secondary
dressings to provide impermeability to microorganisms,
improve adherence, and promote a moist wound envi-
ronment for superficial- to full-thickness abrasions,
avulsions, blisters, lacerations, punctures, and traumatic
and postoperative incisions.* Strength of recommenda-
tion: C
Identification of Infection and Adverse Reactions
28. The athletic training staff should monitor the patient and
wound area for clinical features of wound infection,
including fever, pain, edema, erythema, warmth, wound
dehiscence, and delayed wound healing.124–128 Strength of
recommendation: C
29. For treatment of bacterial infections, refer to the National
Athletic Trainers’ Association position statement on skin
diseases.129 Strength of recommendation: B
30. Infection rates in patients with acute skin trauma can be
reduced with appropriate cleansing, debridement, and
dressing techniques.39,125,130–132 Strength of recommenda-
tion: B
31. Skin antisepsis is effective in reducing the incidence of
surgical-site infections in incisions and lacerations.133
Strength of recommendation: A
Table 2. Sample Dressings
Brand Name Type Manufacturer
Allevyn Foam Smith & Nephew Pty,
Limited, Mount
Waverley, Victoria,
Australia
Aquaflo Hydrogel Covidien, Mansfield, MA
Aquaheal Hydrogel Spenco Medical
Corporation, Waco, TX
Bioclusive Film Johnson & Johnson,
Medical LTD, Ascot,
United Kingdom
Dermabond Dermal adhesive Ethicon, Somerville, NJ
Duoderm Hydrocolloid ConvaTec, Princeton, NJ
Histoacryl Dermal adhesive Aesculap AG, Tuttlingen,
Germany
Leukostrips Wound-closure strip Smith & Nephew Pty
PolyMem Foam Ferris Mfg, Burr Ridge, IL
Polyskin II Film Covidien
SteriStrips Wound-closure strip 3M Company, St Paul, MN
Tegaderm Alginate, film, foam,
hydrocolloid, and
hydrogel
3M Company
Ultec Pro Alginate/
hydrocolloid
Covidien
*References 91, 101, 105, 108, 109, 113, 114, 116, 122, 123.
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32. Oral antibiotics should not be used prophylactically
unless the abrasion, avulsion, blister, incision, laceration,
or puncture is heavily contaminated.134,135 Strength of
recommendation: A
33. Topical antimicrobial agents can reduce infection rates in
acute skin trauma but should be used judiciously given
the emergence of resistant bacterial strains.135–142
Strength of recommendation: A
34. The patient should be monitored for the development of
adverse reactions stemming from the use of some
cleansing solutions, topical antimicrobial agents, and
nonocclusive and occlusive dressings.143–147 Strength of
recommendation: C
35. The patient’s health status (eg, malnutrition, smoking,
diabetes) may contribute to the development of adverse
reactions and should be considered.130,148–161 Strength of
recommendation: B
36. The athletic training staff should monitor the patient and
wound area for clinical features of adverse reactions,
including erythematous rash, eczematous reaction, vesi-
cles, white discoloration, tenderness, nodularity, burning,
pruritus, or systemic reactions such as urticaria and
anaphylaxis.143–146,162–165 Strength of recommendation: C
Table 3. Nonocclusive Dressing Indications
Indications Primary Dressing Secondary Dressing Other Considerations
Clinically infected abrasions,
avulsions, blisters, incisions,
lacerations, and punctures
Woven and nonwoven gauze Woven or nonwoven gauze;
nonadherent pads; adhesive strips
or patches; adhesive gauze;
nonadherent, self-adherent, and
adherent tapes and wraps
Daily dressing changes required
Punctures with cavities Woven, nonwoven, and
impregnated gauze
Woven or nonwoven gauze;
nonadherent pads; adhesive strips
or patches; adhesive gauze;
nonadherent, self-adherent, and
adherent tapes and wraps
Daily dressing changes required
Superficial, linear lacerations and
postoperative incisions
Wound-closure strips Woven or nonwoven gauze;
nonadherent pads; adhesive strips
or patches; nonadherent, self-
adherent, and adherent tapes and
wraps
Use only on wounds with minimal
static and dynamic tension
Superficial- to full-thickness
abrasions, avulsions, blisters,
incisions, and lacerations for
wet-to-moist debridement
Woven gauze Woven or nonwoven gauze;
nonadherent pads; nonadherent,
self-adherent, and adherent tapes
and wraps
Use care to protect healthy
granulation tissues
Superficial- to partial-thickness
abrasions, avulsions, blisters,
superficial-thickness incisions,
lacerations, and punctures as
temporary dressings
Premoistened woven and
nonwoven gauze; nonadherent
pads; adhesive strips or
patches
Woven or nonwoven gauze;
nonadherent pads; adhesive strips
or patches; adhesive gauze;
nonadherent, self-adherent, and
adherent tapes and wraps
Follow-up in athletic training
facility for comprehensive
management
Superficial- to partial-thickness
abrasions, avulsions, blisters,
superficial-thickness incisions,
lacerations, and punctures on
irregular body areas
Woven and nonwoven gauze;
nonadherent pads; adhesive
strips or patches
Woven or nonwoven gauze;
nonadherent pads; adhesive strips
or patches; adhesive gauze;
nonadherent, self-adherent, and
adherent tapes and wraps
Daily dressing changes required
Table 4. Occlusive Dressing Indications
Indications Primary Dressing Secondary Dressing Other Considerations
Superficial- to partial-thickness
abrasions, avulsions, blisters,
incisions, lacerations, and
punctures
Alginates, films, foams,
hydrocolloids, and hydrogels
Films; woven or nonwoven
gauze; adhesive gauze;
nonadherent, self-adherent,
and adherent tapes and wraps
Minimal exudate: films and
hydrogels; moderate exudate:
hydrogels and hydrocolloids;
heavy exudate: alginates and
foams
Partial- to full-thickness
abrasions, avulsions, blisters,
lacerations, traumatic and
postoperative incisions
Alginates, foams, and
hydrocolloids
Films; woven or nonwoven
gauze; adhesive gauze;
nonadherent, self-adherent,
and adherent tapes and wraps
Moderate exudate: hydrocolloids;
heavy exudate: alginates and
foams
Partial- to full-thickness
lacerations and traumatic and
postoperative incisions
Dermal adhesives Films; hydrocolloids; woven or
nonwoven gauze; nonadherent
pads; nonadherent, self-
adherent, and adherent tapes
and wraps
Use only in areas of low skin tension
Clinically infected abrasions,
avulsions, blisters, incisions,
and lacerations
Alginates and foams, silver-
impregnated alginates, films,
foams, and hydrocolloids
Films; woven or nonwoven
gauze; adhesive gauze;
nonadherent, self-adherent,
and adherent tapes and wraps
Minimal exudate: films; moderate
exudate: hydrocolloids; heavy
exudate: alginates and foams;
daily dressing changes required
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37. Treatment of the adverse reaction should consist of
identifying the reaction, removing the causative agent, and
directing appropriate measures at the reaction.143–146,162–165
Strength of recommendation: C
38. Criteria for physician referral include
a. Any evidence of deeper injury that may require repair,
evaluation for nerve or tendon damage, or concern for
heavy contamination. Strength of recommendation: C
b. Wounds that develop erythema, warmth, edema,
drainage, pain, or rash or demonstrate delayed healing.
Strength of recommendation: C
Follow-Up
39. The athletic training staff should visually inspect the
patient, wound area, and dressing daily throughout the
healing process.
a. The visual inspection should include the patient,
wound bed, and periwound tissues for the presence
of adverse reactions and infection. If any signs or
symptoms are present, the patient should be referred to
a physician. Strength of recommendation: C
b. Frequency of dressing changes varies based on the
type of dressing (Table 5). A dressing change is
warranted with evidence of dressing channel forma-
tion, separation from periwound tissues, significant
exudate accumulation, strike-through, leakage, or
wound desiccation.89,91,94,166,167 Strength of recom-
mendation: C
c. Dressing transitions are required as reductions in
exudate and new tissue growth occur during healing.†
Strength of recommendation: C
40. Patients should be educated on dressing guidelines to
increase compliance.
a. Patients should follow instructions from the athletic
training staff on dressing changes. Occlusive dressings
can stay in place over wounds for longer periods than
nonocclusive dressings.91,94,105,122,170–172 Strength of
recommendation: C
b. Patients will notice changes in the dressing over time.
An accumulation of moisture beneath occlusive
dressings may be visually detected or demonstrated
by expansion of the dressing over the wound bed and
should not be confused with infection.91,103,105,173
Strength of recommendation: C
c. Patients must immediately report dressing channel
formation, separation from periwound tissues, seal
breach, strike-through, or leakage or signs or symp-
toms of adverse reactions and infection.89,91,94,166,167
Strength of recommendation: C
Supplies for Athletic Training Facilities and Kits
41. Supplies to manage acute skin trauma should be available
in the athletic training facility.
a. Cleansing: normal saline, potable tap water, 35-mL
syringe, 18- to 20-gauge needle hub or plastic cannula,
antiseptic skin cleanser, and clean basin or cup.
b. Debridement: normal saline, potable tap water, 35-mL
syringe, 18- to 20-gauge needle hub or plastic cannula,
woven gauze, high-porosity sponge or surgical scrub
brush, and sterile scissors and tweezers.
c. Dressings: nonocclusive dressings (woven, nonwoven,
and impregnated sterile gauze, nonadherent pads,
adhesive strips and patches, and wound-closure strips),
occlusive dressings (alginates, films, foams, hydrogels,
hydrocolloids, and dermal adhesives), adhesive gauze,
and nonadherent, self-adherent, and adherent tapes and
wraps.
d. Miscellaneous: sterile or clean (or both) drapes or
towels, biohazard container, boxed gloves, face or eye
shields (or both), and topical antibiotics.
42. Supplies to manage acute skin trauma should be available
in athletic training kits.
a. Cleansing: normal saline, potable tap water, 35-mL
syringe, 18- to 20-gauge needle hub or plastic cannula,
and clean basin or cup.
b. Debridement: same as cleansing.
c. Dressing: nonocclusive dressings (woven and nonwo-
ven sterile gauze, nonadherent pads, and adhesive
strips and patches), adhesive gauze, and nonadherent,
self-adherent, and adherent tapes and wraps.
d. Miscellaneous: boxed gloves, face or eye shields (or
both), and biohazard container.
BACKGROUND
Acute skin trauma is a disruption of the integrity of the
epidermis, dermis, or subcutaneous tissues (or a combina-
tion of these). Acute wounds are characterized based on the
mechanism of injury and resultant tissue damage and
include traumatic abrasions, avulsions, blisters, lacerations,
punctures, and traumatic and postoperative incisions. The
mechanisms of injury of acute skin trauma are shear and
tensile forces and tensile loads.174 Acute wounds can also
be characterized by the amount of tissue damage.175
Superficial-thickness wounds involve damage to the
superficial epidermis. Partial-thickness wounds extend
through the epidermis and into the superficial dermis.
Full-thickness wounds extend through the epidermis and
dermis and into the subcutaneous adipose tissue. Acute
wounds proceed through an orderly and timely reparative
process of inflammation, proliferation, and remodeling that
results in restoration of anatomic and functional integrity
and wound appearance.176 Some have characterized acute
Table 5. Recommended Duration of Wound Dressing Usagea
Dressing Type Duration, d
Woven, nonwoven, and impregnated sterile
gauze; nonadherent pads; and adhesive
strips and patches87,91,93,94,105,113,168
1
Wound-closure strips174 5–10
Alginates105 7
Films and foams91,94,105,122,170 3–7
Hydrogels94,105,122 1–7
Hydrocolloids94,105,122,170 5–7
Dermal adhesives171,172 5–10
a Wounds without dressing-integrity problems (eg, wrinkling or
bunching, channel formation, separation from periwound tissues,
strike-through, leakage of exudate) or clinical features of adverse
reactions or infection.89,91,94
†References 91, 94, 100, 104, 108, 168, 169.
Journal of Athletic Training 1057
wounds as those that heal themselves within 4 to 6
weeks.124
THE EVIDENCE AND LITERATURE REVIEW
Cleansing
Wound cleansing, considered a critical part of the
management of acute skin trauma, is the process of
applying a nontoxic solution to aid in the removal of
exudate, bacteria, foreign debris, and dressing residue to
create an environment conducive for healing.39,177 Acute
wounds are initially considered to be contaminated;
cleansing is necessary to remove any debris and facilitate
healing.9,11,17 After the initial cleansing, it may not be
necessary to cleanse wounds at every dressing change but
rather to rehydrate a wound to create a moist environment,
visualize and assess the wound, minimize trauma during
adherent dressing removal, or promote patient com-
fort.9,12–18,178 If signs of clinical infection are present,
then continued wound cleansing is necessary.
Technique. The selection of an appropriate cleansing
technique is necessary to create an optimal environment for
wound healing (ie, a moist, clean, warm environment). The
more commonly used techniques include irrigation,
showering, hydrotherapy (eg, whirlpool baths and soaks),
and scrubbing and swabbing.
Irrigation. Irrigation, the steady flow of solution across
the wound surface, is the preferred method of cleans-
ing.11,39,179 The purpose of irrigation is to remove loose
debris and excess wound secretions to create an optimal
healing environment. This method allows for newly
granulating tissue to be preserved, bacteria and debris to
be effectively removed, and the comfort and convenience
of the patient to be ensured. The potential risks associated
with this technique include splash back, additional trauma,
and bacteria driven into deeper tissues if the pressure is
excessive.11
Although many irrigation recommendations are based on
trials involving chronic wounds, investigators11,19–25,29,39
agree that high-pressure irrigation (eg, 4–15 psi [27.58–
103.42 kPa]) is the best practice for cleansing superficial- to
full-thickness abrasions, incisions, and lacerations. Au-
thors19 of an evidence-based medicine review found that a
pressure of 13 psi (89.63 kPa) was effective in reducing
infection and inflammation in lacerations and chronic
wounds among children and adults, although no consensus
exists as to the optimal pressure that should be used.
Researchers24 agree that low-pressure irrigation (eg, ,4 psi
[27.58 kPa]) is not as effective in cleansing and serves only
to moisten the wound bed. Pressures greater than 25 psi
(172.4 kPa) may be necessary to debride a wound but are
not recommended for routine cleansing, as they may
damage healthy granulation tissue.13,24
The equipment commonly used for irrigation includes
bulb syringes, pressurized canisters, and syringes with an
attached needle or catheter. A 35-mL syringe with an 18- to
20-gauge needle, needle hub, or plastic cannula exerts
pressures in the range of 7 to 11 psi (48.26–75.84 kPa),
delivering a solution without damage to the tissue.11,19,23,24
Showering. Showering is effective for larger traumatic
wounds, although the pressure is rarely controlled. Authors
of a Cochrane review20 examining the effects of postop-
erative showering versus no showering found strong
evidence of no difference in the infection and healing
rates of incisions. However, investigators19,20 reported that
patients derived a sense of health and well-being from
showering.
Hydrotherapy. Whirlpool baths can be used as an
aggressive form of cleansing; the turbulence of the water
dislodges debris from the wound bed. More often used for
chronic wounds, bathing in lukewarm tap water has become
an increasingly common practice, although its role may be
considered more for debridement than cleansing.11,24,26
Researchers19 suggested that whirlpool therapy may reduce
pain and inflammation in surgical incisions during the first
72 postoperative hours. Clinically, this method of cleansing
may be used to hydrate a wound, even though concerns and
potential risks include disrupting the moisture balance of
the wound bed, macerating periwound tissues, and
impairing healing by introducing microorganisms from
the immersion fluid.11
Scrubbing and Swabbing. Scrubbing and swabbing
involve the use of a material (eg, gauze, foam) to wipe the
surface of the wound in a systematic manner. This method
lacks the evidence necessary to show that it creates the
optimal wound environment: scrubbing and swabbing
redistribute bacteria over the wound as opposed to removing
them.9,13,24,26–29 Cotton wool fiber remnants from woven
gauze often contaminate the wound and have resulted in
nonwoven swabs being the material of choice for swab-
bing.9,13,29 Swabbing can be used to cleanse the periwound
tissues or wounds with loose necrotic tissue or slough (moist
necrotic tissue).26,27 However, others9,13,24,26–29 caution
against using the swabbing technique on the wound bed
because of residual damage to the granulating tissue.
Overall, no evidence supports or refutes scrubbing and
swabbing to cleanse wounds.19
Solutions. The selection of an appropriate nontoxic
solution to remove debris and create an environment to
promote healing is a critical component of wound
cleansing. Various cleansing solutions are recommended
for their therapeutic value.180 The characteristics of an ideal
solution are nontoxicity to human tissue, effectiveness in
the presence of organic material, ability to reduce the
number of microorganisms, low likelihood of causing
sensitivity reactions, cost-effectiveness, availability, and
shelf-life stability.41,178,181 Based on these characteristics,
many authors7,12,20,182 consider normal saline the most
appropriate cleansing solution for acute skin trauma,
although the use of potable tap water has become more
widely accepted.
Normal Saline and Potable Tap Water. In a number of
evidence-based medicine reviews, researchers19,20,25,30–33
have examined the effectiveness of normal saline and
potable tap water on rates of infection and healing in acute
wounds. Good evidence shows that effective cleansing can
be achieved with normal saline or potable tap water. In a
Cochrane review20 comparing normal saline and tap water
as cleansers, the incidence of infections among various
acute wounds and sutured lacerations in adults was reduced
with the use of tap water. It is notable that the solutions
were at different temperatures in the trials: normal saline at
room temperature and tap water at 98.68F (378C). However,
water from a properly treated supply and run from the tap
for a few minutes before use does not increase the risk of
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contamination and infection.178 Tap water has the advan-
tages of being efficient, cost-effective, and accessible.20 Yet
tap water should not be used to cleanse wounds in which
tendon or bone is exposed. Normal saline is the
recommended solution for these wounds.34
Antiseptics. Topical antiseptics are antimicrobial
agents that kill or reduce the number of microorganisms
that may impede wound healing. Commonly used solutions
include povidone-iodine (eg, Betadine; Purdue Products
LP, Stamford, CT) and hydrogen peroxide.36,38–41,183,184
However, the use of antiseptics as prophylactic antimicro-
bial agents for acute skin trauma has been controversial for
many years.35–37,40,184
Several investigators19,37 have examined the effects of
povidone-iodine and the product Betadine on rates of
infection and healing. In 1 evidence-based medicine
review,19 infection rates were compared between acute
wounds that were cleansed with 1% povidone-iodine or
with normal saline. Among contaminated postoperative
incisions and traumatic lacerations, 1% povidone-iodine
was favored over normal saline. An individual trial in this
review19 examining lacerations demonstrated no differenc-
es in infection rates between 1% povidone-iodine and
normal saline. Authors37 of a more recent evidence-based
medicine review examined the use of iodine and other local
wound care methods (eg, honey, silver-impregnated
dressings) on postoperative incisions and various acute
wounds and noted no differences in rates of infection or
healing. An additional narrative review35 examining the
effects of povidone-iodine on healing in animal and human
wound models has raised questions about the benefits of the
solution; delayed wound healing, reduced wound strength,
and increased rates of infection were noted when acute skin
trauma was treated with the antiseptic. In a small
investigation, researchers41 demonstrated the safe use of
antimicrobials in diluted concentrations. A 1 : 10 diluted
solution of Betadine was effective against bacteria and not
harmful to human fibroblasts.41 A 1 : 5 diluted solution of
Betadine was toxic to fibroblasts and, therefore, one may
conclude that the commercially produced solution of
Betadine would be toxic as well.41
Other investigations have examined the efficacy of
hydrogen peroxide as an antiseptic in animal and human
wound models. In a narrative review,38 hydrogen peroxide
demonstrated minimal effects in reducing the bacterial
bioburden (quantity of microorganisms), but the findings
were inconclusive regarding cytotoxic effects on tissues
and rates of healing. Small experimental investigations41,42
support the finding that hydrogen peroxide is ineffective in
reducing microorganisms in the wound bed. However, these
trials demonstrated a greater cytotoxic effect of hydrogen
peroxide on tissues,42,43 which perhaps delayed healing.
Temperature. Athletic trainers must also consider the
temperature of the solution to facilitate healing. The
recommended temperature of the cleansing solution is
between 98.68F and 107.68F (378C and 428C).13,14,44,45
Mitotic activity (reproduction of cells essential to healing)
decreases as the wound temperature drops after cleansing or
dressing changes. It can take up to 40 minutes for the
wound bed to return to its original temperature and up to 3
hours for mitotic activity to return to normal.45 Therefore,
using a cool cleansing solution may delay the healing
process.14 Although research directly examining the effects
of various solution temperatures on wound healing is
lacking, some evidence suggests that lower temperatures
may delay wound healing.45
Debridement
Debridement is the removal of necrotic or devitalized
tissue, microorganisms, contaminated tissue, fibrin or
foreign bodies, and cellular debris from the wound
bed.53,54,75,185 After acute skin trauma, debridement should
be used to decrease the risk of infection and create an
environment suitable for healing. Thorough cleansing of the
wound should be performed initially and, if necessary,
debridement used to remove remaining debris or devital-
ized tissue from the wound bed. The wound should be
debrided until only normal vascularized tissue remains.54,56
Debridement can decrease the bacterial concentration
within the wound bed, decreasing the bacterial bioburden83;
improve the function of leukocytes, reducing the risk of
infection; shorten the inflammatory phase, decreasing the
energy required for healing; and remove debris and tissue
from the wound bed, eliminating the physical barrier to
healing.66
Technique. Many debridement methods are available to
health care providers. The methods that ATs can consider
using include irrigation, hydrotherapy, wet-to-dry, wet-to-
moist, scrubbing, conservative sharp, chemical, and
autolytic debridement.
Irrigation. Irrigation is the delivery of normal saline or
potable tap water to the wound bed in a constant or pulsed
stream.3,57–59 Irrigation can serve as an extension of
cleansing to remove loose superficial debris or necrotic
tissue from superficial- to full-thickness abrasions, avul-
sions, blisters, incisions, lacerations, and punctures.3,57–59
Recommended pressure ranges from 4 to 15 psi (27.58–
103.4 kPa) for all wounds except punctures, for which 2 to
4 psi (13.79–27.58 kPa) is recommended to avoid driving
debris and contaminants deeper into the wound.3,57,59,61
Hydrotherapy. Whirlpool baths and soaks use potable
tap water to soften and remove devitalized tissue and toxic
debris and dilute the bacterial content of the wound bed.
The body part and wound are submerged in water between
95.98F and 102.28F (35.58C and 39.08C) for 20 to 30
minutes.63 Although commonly used, hydrotherapy is not
recommended for acute skin trauma. This technique can
increase the risk of cross-contamination from the whirlpool
tub or other container, and it is neither cost-effective nor
time-effective to drain, properly clean and disinfect, and
refill the whirlpool tub or container after each patient.63
Wet to Dry. Wet-to-dry debridement is the use of
woven gauze with large pores that is premoistened with
normal saline, potable tap water, or chemicals and placed
directly on the wound bed.55 The gauze is allowed to
remain on the wound bed undisturbed for 8 to 24 hours until
dry and then quickly removed.66,68 Devitalized tissue
adheres to the gauze as drying occurs and is debrided from
the wound with removal of the gauze. Wet-to-dry
debridement is not recommended for acute skin trauma.
Wet-to-dry debridement is nonselective in tissue removal;
as a result, healthy granulation tissue may also adhere to the
gauze and be removed, adversely affecting the healing
process57,59,64,67,69 and causing additional pain.65,70
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Wet to Moist. Similar to wet-to-dry debridement, wet-
to-moist debridement is the placement of woven gauze with
large pores that is premoistened with normal saline or
potable tap water over the wound bed. The gauze is allowed
to remain on the wound bed for minutes to hours and
removed before drying is complete. Wet-to-moist debride-
ment may be used for superficial- to full-thickness
abrasions, avulsions, blisters, incisions, and lacerations.
This technique is a rapid method of debridement and allows
for removal of debris, devitalized tissue, and eschar (black
necrotic tissue, scab), while protecting healthy granulation
tissue and producing minimal pain.59
Scrubbing. Scrubbing is the use of a sponge with high
porosity (90 pores/in2 [14 pores/cm2]) or a surgical scrub
brush, along with normal saline or potable tap water, to
scour the wound bed from the middle toward the wound
margins in a circular pattern.66 Scrubbing can be used with
superficial- to partial-thickness abrasions, avulsions, blis-
ters, incisions, and lacerations contaminated with large
quantities of small debris (eg, sand, grass, clay, asphalt).66
This technique is nonselective, with potential removal of
healthy granulation tissue, and the mechanical pressure of
the sponge or brush can produce pain.
Conservative Sharp Debridement. Conservative sharp
debridement is the use of sterile scissors and forceps or
tweezers to remove loosely adhering devitalized tissue that
lies superficial to viable tissue on the wound bed.71
Conservative sharp debridement of acute skin trauma is
typically performed in a single visit and may be used on
superficial- to full-thickness abrasions, avulsions, blisters,
incisions, and lacerations.72 Applicable state practice acts
may allow ATs to perform this technique but should be
verified.174
Chemical Debridement. Chemical debridement is the
application of sodium hypochlorite, hydrogen peroxide, or
povidone-iodine in water-based solutions; silver; or honey
directly to the wound bed or the use of chemical-
impregnated dressings over the wound. Although chemicals
may facilitate debridement, their use is controversial and
not recommended for acute skin trauma.71,73,74 Some
authors have recommended chemicals for debridement of
infected wounds71 or with wet-to-moist debridement.75 The
effervescent effect of hydrogen peroxide may aid debride-
ment, but hydrogen peroxide and sodium hypochlorite are
thought to be cytotoxic to healthy granulation tissue.74
Silver and silver-impregnated dressings have been used for
centuries to provide antimicrobial debridement of colonized
and clinically infected wounds. In an evidence-based
medicine review, Vermeulen et al121 demonstrated insuffi-
cient evidence for the use of silver-impregnated dressings
to manage contaminated or infected acute and chronic
wounds.
Autolytic Debridement. Autolytic debridement is the
use of the body’s mechanisms to promote proteolytic
digestion of necrotic tissue in a moist environment created
by the application of occlusive dressings such as alginates,
films, foams, hydrogels, and hydrocolloids.76,79,83,85 The
moist environment allows endogenous collagenase en-
zymes within the wound to liquefy necrotic tissue, which
can then be more easily digested by macrophag-
es.51,55,57,58,75,77,80,82 The body selectively digests only
nonviable tissue and the moist environment allows for
painless debridement.71 Autolytic debridement can be used
with superficial- to full-thickness abrasions, avulsions,
incisions, and lacerations; superficial- to full-thickness
blisters after removal of the necrotic roof with conservative
sharp debridement71; and superficial- to partial-thickness
punctures. Autolytic debridement is slow, occurring over
several days, and is not recommended for infected
wounds.57,66,75
In an evidence-based medicine review, Lewis et al79
examined the use of dressings in the autolytic debridement
of postoperative incisions. Overall, modern occlusive
dressings were favored over gauze dressings for healing.
Findings from individual trials in the review79 produced no
clear evidence of differences in rates of healing among
polyurethane foam, silicone foam, and alginate dressings.
Several authors78,81,84 have investigated the effectiveness of
autolytic, wet-to-dry, and enzymatic debridement among
various chronic wounds. Autolytic debridement using
hydrogel and hydrocolloid dressings and wet-to-dry
debridement using normal saline-soaked gauze produced
a satisfactory environment to promote healing of pressure
ulcers.81 In this study, the hydrogel dressing was preferred
because the transparent construction allowed for visual
assessment of the wound bed and removal of the dressing
did not damage healthy tissue. Other authors84 have shown
hydrogel dressings to be effective in managing chronic and
necrotic wounds with slough. For debridement of leg
ulcers, no differences were demonstrated between autolytic
and enzymatic debridement in rates of healing.78
Dressings
It is well established that acute wounds should be covered
with a dressing to support the healing process rather than be
left uncovered and exposed to the external environ-
ment.2,86–90 Dressings used with acute skin trauma must
promote an environment that will facilitate complete
healing in the shortest possible amount of time.100,112 A
variety of nonocclusive and occlusive dressings are
available, but purchasing a wide selection is likely not
cost-effective for athletic training facilities. Athletic
trainers may choose to select and become proficient in
using a few brands of dressings from each category.
Nonocclusive Dressings. Nonocclusive dressings are
readily accessible and used in most athletic training
facilities for the management of acute skin trauma.181,186
These dressings are available in a variety of forms and
include woven, nonwoven, and impregnated sterile gauze,
nonadherent pads, adhesive strips and patches, and wound-
closure strips.
Primary Dressings. Primary dressings are designed to
make contact with the wound bed.187 Nonocclusive
dressings can be used as primary dressings for several
wound types. Woven and nonwoven gauze can be used for
clinically infected abrasions, avulsions, blisters, incisions,
lacerations, and punctures.91,92 These dressings can be
applied alone or in combination with topical antimicrobial
agents91,92 and may be cost-effective when compared with
other dressings.91 Woven, nonwoven, and impregnated
gauze strips and rolls can be used for puncture wounds with
cavities.93–96 The dressings eliminate dead space, prevent
premature closure of the wound surface, and allow healing
to occur from the wound base upward.93–96,188 Wound-
closure strips can be used for superficial, linear lacerations
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and postoperative incisions with minimal static and
dynamic tension.3,97,98 Woven gauze with an open-weave
pattern can be used for mechanical (wet-to-moist) debride-
ment of superficial- to full-thickness abrasions, avulsions,
blisters, incisions, and lacerations.55,68,91
Woven and nonwoven gauze, nonadherent pads, and
adhesive strips or patches premoistened with normal
saline95,99 or potable tap water can be used as temporary
primary dressings for superficial- to partial-thickness
abrasions, avulsions, and blisters and superficial-thickness
incisions, lacerations, and punctures.91 This dressing
technique is appropriate when an immediate return to
physical activity is necessary. Further evaluation and
appropriate cleansing, debridement, and dressing should
be conducted in the athletic training facility. Woven and
nonwoven gauze, nonadherent pads, and adhesive strips or
patches can also be applied to wounds sustained on
irregular body surfaces when other dressings cannot be
held in place.
Secondary Dressings. Secondary dressings are de-
signed to be used in combination with primary dressings to
provide additional absorption, protection, or occlusion for
the wound bed.187 Woven or nonwoven gauze, nonadherent
pads, and adhesive strips or patches can be used as
secondary dressings for superficial- to full-thickness
abrasions, avulsions, blisters, lacerations, punctures, and
traumatic and postoperative incisions.91,94,100,101 Woven and
nonwoven gauze can be applied over the primary dressing
to absorb moderate-to-heavy amounts of exudate, which
can leak from or strike through the primary dressing.100
Strike-through is the leakage of exudate from the wound
bed that becomes visible through the dressing. Gauze and
nonadherent pads can provide additional padding and
protection to the wound. Roll gauze and adhesive strips
or patches can also assist in securing the primary dressing
to the periwound tissues.
Occlusive Dressings. Semipermeable and impermeable
occlusive dressings are designed to interact with the wound
to facilitate healing and lessen the risk of infection and
adverse reactions. Among the numerous classes of
occlusive dressings, alginates, films, foams, hydrogels,
hydrocolloids, and dermal adhesives are the most accessible
to ATs for managing acute skin trauma.
Primary Dressings. For several wound types, occlusive
dressings should be used as primary dressings and applied
directly to the wound bed. Alginate, film, foam, hydrocol-
loid, and hydrogel dressings should be used for superficial-
to partial-thickness abrasions, avulsions, blisters, incisions,
lacerations, and punctures.2,90,91,95,102–112 Films and hydro-
gels are indicated for superficial-thickness wounds based on
their ability to manage low levels of exudate. Films are
nonabsorbent; with higher levels of exudate, channels
(progression of exudate from the wound bed to the
perimeter of the dressing) can form in the dressing and
compromise the seal edge and barrier properties with
subsequent leakage.91 Hydrogels can absorb minimal-to-
moderate amounts of exudate and are unique in that they
can also donate moisture to the wound bed,107 thereby
lowering the risk of desiccation in minimally draining
superficial wounds.108 Partial-thickness wounds with mod-
erate exudate should be managed with hydrocolloids or
hydrogels. Hydrogels should be closely monitored because
maceration of the wound and periwound tissues can occur
from the high water content and slow absorption of
exudate.103,106 Alginate and foam dressings are indicated
for partial-thickness wounds with heavy exudate. High
absorbency allows alginates and moderate-to-high moisture
vapor transmission (evaporation of fluid from the wound
bed through the dressing) and high absorbency enables
foam dressings to manage large amounts of exudate.104
Partial- to full-thickness abrasions, avulsions, and blisters
should be managed with alginates, foams, and hydrocol-
loids; lacerations and incisions can be managed with
alginates, foams, hydrocolloids, or dermal adhesives.‡
Hydrocolloids should be applied to partial- to full-thickness
abrasions, avulsions, and blisters accompanied by moderate
exudate.109,115 Hydrocolloids can also be used for lacera-
tions and traumatic and postoperative incisions with
moderate exudate and adequate tissue approxima-
tion.113,114,116 Alginates and foams should be used to
manage the heavy exudate typically produced by partial-
to full-thickness abrasions, avulsions, blisters, lacerations,
and traumatic and postoperative incisions with adequate
tissue approximation.91,109,117 Lacerations and traumatic
and postoperative incisions in areas of low skin tension that
require tissue approximation can be closed with dermal
adhesives.97,98,118,119
Several classes of occlusive dressings can be used for
contaminated and clinically infected wounds. Alginates and
foams can be applied to clinically infected abrasions,
avulsions, blisters, incisions, and lacerations.91,94,120,121 The
high absorbency of these dressings can effectively manage
the significant amounts of drainage associated with
infection, but daily changes are required.91,94,120 Antimi-
crobial silver dressings can be used for contaminated and
clinically infected abrasions, avulsions, blisters, incisions,
and lacerations.120,121 Alginate, film, foam, and hydrocol-
loid dressings are available with different concentrations
and release rates of silver.
Secondary Dressings. Occlusive dressings can be used
as secondary dressings in combination with primary
dressings on superficial- to full-thickness abrasions,
avulsions, blisters, lacerations, punctures, and traumatic
and postoperative incisions. Although most occlusive
dressings are available in sheet form with an adhesive
backing, some foams and hydrogels are nonadhesive and
require a secondary dressing.91,105,108,109 Films are appro-
priate as secondary dressings to secure foams and
hydrogels to provide occlusion122 and can also be applied
in combination with other occlusive dressings in sheet
form for additional adherence to the periwound tissues and
to prevent leakage of excess exudate from heavily
draining wounds. Films and hydrocolloids can serve as
secondary dressings for lacerations and traumatic and
postoperative incisions that have been closed with
sutures,3,101,113,114,116,123 staples,101 or dermal adhe-
sives.3,101
Healing. Authors of evidence-based medicine reviews
have focused on nonocclusive and occlusive dressing
interventions for split-thickness skin graft (STSG) donor
sites and traumatic and postoperative wounds in various
populations. Among the broad categories of nonocclusive
and occlusive dressings, strong evidence indicated that
occlusive dressings were favored over nonocclusive
‡References 2, 90, 91, 97, 98, 102, 106, 109–119.
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dressings for rates of healing in STSGs.102 This surgical
wound is the equivalent of a superficial- to partial-thickness
abrasion.175 In the review,102 hydrocolloids and films were
favored over nonocclusive dressings and hydrocolloids
were also superior to other occlusive dressings for healing.
Individual trials in the review102 revealed that alginates and
foams were superior to nonocclusive dressings for healing.
An additional review111 showed no differences among
nonocclusive and occlusive dressings in rates of healing
among STSGs and postoperative incisions. An individual
trial in this review111 demonstrated that foams were
superior to nonocclusive dressings in healing of STSGs.
Evidence-based reviews examining the effects of
nonocclusive and occlusive dressings impregnated with
silver on uninfected189 and contaminated and infected121,190
acute and chronic wounds provide no clear evidence to
support their effectiveness in increasing healing rates.
Authors of other evidence-based medicine reviews have
reported on the efficacy of dermal adhesives for traumatic
and postoperative wounds. A Cochrane review98 examined
standard wound closure (sutures, staples, wound-closure
strips) and dermal adhesives for postoperative incisions.
The findings demonstrated that sutures lessened dehiscence
(separation of wound edges); wound-closure strips im-
proved surgeons’ assessments of cosmetic appearance; and
sutures, staples, and wound-closure strips increased sur-
geons’ satisfaction regarding ease of use. For time to
complete closure, the review revealed inconsistent findings
between standard wound-closure techniques (sutures,
staples, wound-closure strips) and dermal adhesives.
Among dermal adhesives, low-viscosity adhesive was
favored over high-viscosity products, and octyl cyanoacry-
late was favored over butyl cyanoacrylate for time to
complete closure. An additional Cochrane review97 report-
ed on dermal adhesives and standard wound closure
(sutures, staples, wound-closure strips) for traumatic
lacerations. Dermal adhesives lessened pain, the time to
complete closure, and the rate of erythema but increased the
risk of dehiscence. No differences were found in cosmetic
outcomes. Standard wound-closure techniques (sutures,
staples, wound-closure strips) were favored as easier to
use. A comparison of the dermal adhesives butyl cyanoac-
rylate and octyl cyanoacrylate demonstrated no differences
in levels of pain, time to complete closure, dehiscence, or
cosmetic outcome.
Experimental and clinical investigations present addi-
tional evidence for the benefits of occlusive dressings. In
several small trials examining rates of healing in standard-
ized abrasions, authors found that hydrocolloids and films
were superior to nonocclusive dressings,90 other occlusive
dressings,2,112 and no dressing.2,90 Hydrocolloids used as
secondary dressings for sutured traumatic lacerations and
postoperative incisions showed increased patient mobili-
ty191,192 and greater exudate control192 when compared with
nonocclusive dressings. For rates of healing, findings were
inconsistent when hydrocolloids as secondary dressings for
sutured and nonsutured lacerations and incisions were
compared with nonocclusive dressings.113,193,194
Pain. Increased levels of pain are associated with the use
of nonocclusive dressings. In an evidence-based medicine
review, Wiechula102 noted that nonocclusive dressings used
as primary dressings for STSGs produced greater levels of
pain on visual analogue scales at rest and with ambulation
than occlusive dressings. Findings from individual trials in
the review102 demonstrated that hydrocolloids, films, and
foams resulted in less pain than nonocclusive dressings.
Several authors191,194,195 have shown that hydrocolloids
used as secondary dressings decreased levels of pain in
sutured lacerations and postoperative incisions compared
with nonocclusive dressings.
Infection. Rates of infection with various nonocclusive
and occlusive dressings have been reported in the literature.
In a review110 of 75 studies (3047 wounds) examining
infection under occlusive dressings and 36 studies (1085
wounds) examining infection under nonocclusive dressings
used as controls for occlusive dressings, researchers
demonstrated overall infection rates of 2.6% and 7.1%,
respectively. This significant finding in overall rates was
supported by further analyses of infection for dressings by
wound type (eg, ulcers, burns, STSGs, abrasions, and
lacerations), with occlusive dressings favored over
nonocclusive dressings.110 In an evidence-based medicine
review,102 occlusive dressings produced less infection than
nonocclusive dressings in the management of STSGs.
Among specific dressings, hydrocolloids and films were
favored over nonocclusive dressings for decreased rates of
infection. In a Cochrane review,97 rates of infection did not
differ between the dermal adhesives butyl cyanoacrylate
and octyl cyanoacrylate in the closure of traumatic
lacerations. In contrast, a separate Cochrane review98
revealed no differences in rates of infection between
nonocclusive standard wound closure (sutures, staples,
wound-closure strips) and occlusive dermal adhesives in
closure of postoperative incisions. Authors of several
evidence-based medicine reviews examined the effects of
nonocclusive and occlusive dressings impregnated with
silver on uninfected189 and contaminated and infected121,190
acute and chronic wounds. No clear evidence supported
their effectiveness to prevent or control infection. An
evidence-based review101 examined the efficacy of
nonocclusive and occlusive dressings for postoperative
incisions healing by primary intention (tissue approximation
using sutures, staples, dermal adhesives, or a combination of
these). The authors101 found no clear evidence for differences
in rates of surgical-site infection among nonocclusive
dressings, occlusive dressings, and no dressings.
Additionally, there was no clear evidence for the most
effective dressing to lessen rates of infection.
Identification of Infection and Adverse Reactions
The goal in treating acute skin trauma is to achieve rapid
healing while providing optimal function and cosmetic
results and minimizing adverse events. Adverse outcomes
may occur when a phase of healing is delayed or prolonged;
may result from the cleansing, debridement, or dressing
technique or material used; or be due to the health status of
the patient. Most acute skin trauma heals without
consequence, although it is important to manage these
wounds appropriately to lessen the number of poor
outcomes and allow functional return to activity as quickly
as possible.
Infection. The most common cause of impaired wound
healing is infection.130 In acute skin trauma, the barrier to
bacteria is compromised by disruption of the epidermis,
dermis, or subcutaneous tissues (or all 3) and loss of
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protective defense mechanisms. Wounds can then become
contaminated with bacteria. Although bacteria are present,
multiplication of bacteria has not yet taken place.126
Colonization is a normal state, with multiplying
microorganisms present in the wound but no host reaction
and no clinical indication or evidence of tissue damage.196
Bacterial contamination of the wound will not delay the
healing process, and colonization of skin microflora may
actually enhance healing.39 Healing becomes impaired
when colonization progresses to critical colonization and
then to infection.39 Critical colonization is the transition
state between colonization and invasive wound infection.196
Critical colonization is reached when the host defenses are
unable to maintain the balance of organisms at
colonization.126 This transition period is a multifactorial
process and is specific to the individual patient and the
particular bacteria in the wound.126 At critical colonization,
the granulation bed of the wound may appear unhealthy,
but there is no tissue invasion and the only clinical feature
may be delayed healing.196
Infection occurs when the presence of multiplying
bacteria overwhelms the host defenses and subsequent host
injury occurs.126 The most common causes of uncompli-
cated skin and soft tissue infections are group A b-
hemolytic Streptococcus and Staphylococcus aureus bac-
teria.197–202 Data from the SENTRY Antimicrobial Surveil-
lance Program monitoring skin and soft tissue infections
indicated that S aureus was the most common pathogen
among complicated and hospitalized patients, followed by
Pseudomonas aeruginosa, Enterococcus, Escherichia coli,
Enterobacter, Klebsiella, and Streptococcus.203 Streptococ-
cal infections may be underrepresented because many
cases, in contrast with other organisms, are mild and do not
require patients to be hospitalized.204 Additionally, the
incidence of streptococcal infections is difficult to assess
given the lack of specimens and reliance on studies using
unconventional identification methods.197 The progression
to infection is multifactorial and depends on the number of
bacteria, their virulence and pathogenicity, and the host’s
ability to mount an immune response.196 Intact skin often
contains microflora at 105 organisms per gram of tissue.196
Infection can occur when the level of bacterial growth
exceeds 105 organisms per gram of tissue, although it can
also occur at lower levels for more virulent bacteria such as
b-hemolytic Streptococcus.125 Depending on the nature of
the wound and the organism involved, more than 50% of
patients with wounds containing .105 organisms per gram
of tissue will develop an infection.205 Factors affecting
wound infection include history, location, and timing,
which can predict the level of bacteria in a wound.130 The
longer the time from injury until treatment, the greater the
bacterial bioburden of the wound. The mean time for those
with .105 organisms per gram of tissue is 5.17 hours from
the time of injury.130 When an infection does occur, wound
healing is impaired through multiple mechanisms. Infection
decreases oxygen tension; prolongs the inflammatory
phase; impairs leukocyte chemotaxis and migration,
phagocytosis, intracellular killing, angiogenesis, and epi-
thelialization; and produces collagen breakdown.124
Clinical features of infection are due to the excessive
inflammatory response surrounding the wound. Cellulitis
occurs when the infection spreads through the dermis and
subcutaneous tissue.134 Signs and symptoms may include
fever, pain, edema, erythema, warmth, wound dehiscence,
and delayed wound healing.124–128 Cellulitis borders are
smooth and ill defined. Patients with more severe infections
may present with vesicles, bullae, pustules, necrosis,
ascending lymphangitis, and regional lymphadenopathy.127
Infection should be recognized and addressed promptly to
prevent progression. Antibiotic treatment should be direct-
ed toward the most common pathogens or suspected cause
of infection.197–202 Systemic antibiotics rather than topical
antibiotics are appropriate for cellulitis. For nonpurulent
cellulitis, empiric treatment is aimed at b-hemolytic
Streptococcus and methicillin-susceptible S aureus and
increasing coverage for community-associated methicillin-
resistant S aureus (CA-MRSA) for those who worsen in 48
hours or develop an abscess.204 If a simple abscess is
present or the wound is draining purulent material, the
patient should be referred to a physician for possible
incision and drainage. If the wound is drained and the
infection does not appear to be spreading through the
subcutaneous tissue, then systemic antibiotics are not
needed.130 For those with a purulent cellulitis, empiric
antibiotic therapy is given for CA-MRSA.204 More
information on the treatment of bacterial skin infections
can be found in the National Athletic Trainers’ Association
position statement on skin diseases.129
Prevention of infection is paramount to optimizing
healing of acute skin trauma. Wound cleansing, debride-
ment, dressing techniques, and antimicrobials may all play
roles in preventing infection.39,125,130–132 Skin antiseptics
and systemic and topical antibiotics also play roles in
preventing infection. Antiseptics such as iodine and
chlorhexidine decrease bacterial counts and the number of
bacteria colonizing the skin. An evidence-based medicine
review133 demonstrated that skin antisepsis was effective in
reducing the risk of surgical-site infection. Therefore, it
may be beneficial to cleanse periwound tissues with an
antiseptic before primary closure of traumatic incisions and
lacerations with wound-closure strips or dermal adhesives.
Systemic and topical antibiotics should be used appro-
priately by a physician because of the potential for side
effects and development of resistance. Prophylactic sys-
temic antibiotics are rarely needed, because acute wounds
that are not grossly contaminated and have undergone
appropriate cleansing and debridement have very low
overall infection rates.135 Authors134 of an evidence-based
medicine review evaluating prophylactic antibiotics for
simple, nonbite wounds in the emergency room found they
offered no benefit for lessening rates of infection. Overall,
prophylactic antibiotics resulted in a greater incidence of
infection compared with controls.134 However, the use of
prophylactic systemic antibiotics should be considered
when associated risk factors for infection are present. Soft
tissue injuries associated with a fracture, an animal or
human bite, or an intraoral laceration are treated with
antibiotics for 3 to 5 days, with the medication and length
of treatment dependent on the injury type.138 Prophylactic
antibiotics should also be considered when factors associ-
ated with a higher risk of infection are present. These
include mechanism of injury, amount of tissue damage,
presence of contaminants, location of wound, comorbid
medical conditions, and age of the wound. Wounds that are
visibly contaminated or deep, expose tendon or bone, are
jagged or stellate, or contain foreign bodies are considered
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at higher risk of infection.138,206 Location of the wound
predicts infection: infection rates are higher in the thigh and
arm and lower in the face and scalp.207 Patient comorbid-
ities, including extremes of age, diabetes, chronic renal
failure, obesity, malnutrition, and immunocompromise due
to illness or medications, can increase the risk of
infection.138 Wounds that receive delayed treatment are at
higher risk, and a delay greater than 10 hours becomes an
important risk factor for infection.207 Questions regarding
the need for systemic prophylactic antibiotics require the
patient to be referred to a physician. Topical antimicrobial
agents may effectively reduce rates of infection with acute
skin trauma. Authors142 of a small review of clinical
investigations examining the efficacy of topical antimicro-
bials revealed a decrease in infection rates among
superficial- and partial-thickness abrasions, lacerations,
punctures, and sutured lacerations compared with topical
preparations without an antibiotic. Findings from individual
trials in this review142 showed no differences in rates of
infection among triple antibiotic (neomycin, bacitracin,
polymyxin B), mupirocin, bacitracin zinc ointment, and
povidone-iodine cream. However, the period of use should
be limited to help prevent emergence of resistant bacterial
strains, hypersensitivity reactions, and adverse effects on
wound healing.135–141
Adverse Reactions. Adverse reactions may occur with
materials used to treat acute skin trauma. Allergic contact
dermatitis can be caused by cleansing solutions and
dressings but is more common with topical antimicrobial
agents and neomycin in particular.145,162 Clinical features
vary and may include pruritus, eczematous plaque, edema
and erythema with vesicles, or more generalized
dermatitis.162 Treatment involves removal of the
offending substance and application of topical
corticosteroids.162 Patients with more severe cases may
require systemic corticosteroids and oral antihistamines.162
Less frequently, immunoglobulin E-mediated allergic
reactions and anaphylaxis may occur with topical
antimicrobial use. Clinical features occur shortly after
administration and can include pruritus, urticaria, dyspnea,
throat swelling, nausea, diarrhea, dizziness, and death.143,144
Treatment of anaphylaxis is emergent and includes
epinephrine, corticosteroids, and antihistamines.143
Chemical burns have occurred from prolonged contact
with povidone-iodine in whirlpool baths and soaks or under
an occlusive device or dressing.163 Povidone-iodine has also
been associated with metabolic acidosis, cardiovascular
instability, renal insufficiency, and death when used
indiscriminately for large wounds.40,163 Patients with
chemical burns may present with pain, well-demarcated
erythema, bullae, and vesicles. Treatment is supportive with
topical antibiotics and dressings that promote healing.163
Foreign-body reactions can develop from the use of dermal
adhesives.146 Clinical features are wound-site tenderness
followed by the appearance of a tumor or mass.146 The
adhesive should be removed and the wound monitored.146
Nonocclusive and occlusive wound dressings have been
implicated in immediate and delayed reactions due to
occlusion or excessive adhesion of the dressing to the
wound.147 Folliculitis, caused by occlusion of the skin,
occurs at the base of hair follicles over the periwound
tissues.208 Clinical features may include multiple papules
and pustules in areas covered by an occlusive dressing,
commonly areas that were shaved before dressing applica-
tion. Treatment consists of dressing removal and referral
for possible culture and systemic antibiotic therapy.208
Maceration, which is often associated with chronic wounds,
may also occur from acute skin trauma and contribute to
delayed healing.164 It is a function of wound exudate and
can extend the wound and contribute to pain.164 Maceration
can be identified clinically by white discoloration of the
periwound tissues. Erythematous maceration can occur,
causing the skin to appear red and inflamed, and be
associated with burning, stinging, or itching.165 Wounds
that are developing maceration require dressing removal
and reassessment to determine if dressing selection,
prolonged dressing wear time, or associated infection is
contributing to the production of exudate.164,165 Desiccation
of nonocclusive dressings and adhesion of occlusive
dressings to the wound bed require remoistening before
removal to prevent tissue avulsion.57,59,64,67,69,91
Adverse outcomes may occur because of the status or
health of the patient. Although the data are inconclusive,
malnutrition may contribute to a delay in healing and the
development of infection.154 Anti-inflammatory medica-
tions such as topical or systemic steroids,155,156 nonsteroidal
anti-inflammatories,157,158 and COX-2 inhibitors159 may
suppress wound healing. Smoking may also impair healing
for multifactorial reasons, including a decrease in collagen
production. Diabetes may delay tissue repair and wound
contraction, reduce incision-breaking strength, and increase
susceptibility to infection.160 Wound healing may also be
delayed in those with chronic renal insufficiency, acute or
chronic liver disease, peripheral vascular disease, or
AIDS.130,148–153,161
Criteria for Referral. Most patients with acute skin
trauma can be treated by ATs without complication.
Indications for physician referral include deep wounds that
require tissue approximation with sutures or staples; heavily
contaminated wounds that require more extensive cleansing,
debridement, or possibly prophylactic antibiotics; and
wounds with tendon or nerve injury. Consideration for
referral of an acute uncomplicated wound should be given for
patients with immunocompromised conditions. Patients with
wounds that can be managed in the athletic training facility
should be treated and followed closely. A delay in normal
healing, development of an allergic reaction, or clinical
features of infection or adverse reactions including erythema,
warmth, edema, pus, or pain inconsistent with findings
require physician referral.
Follow-Up
Appropriate management of acute skin trauma requires
the AT to monitor the patient, the wound area, and the
dressing until healing is complete. Daily visual inspections
of the patient, wound bed, and periwound tissues are
performed to identify signs and symptoms associated with
the development of adverse reactions and infection. Some
dressings (eg, wound-closure strips, films, hydrogels,
dermal adhesives) can remain in place while the AT
partially visualizes the wound bed.
Daily visual inspections of the dressing are also used to
guide the frequency of dressing changes. Changes are based
on the type of dressing being used, dressing integrity,
barrier and absorbency properties, and healing of the
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wound. Nonocclusive and occlusive dressings are designed
to remain on the wound bed for varying periods of time in
the absence of dressing-integrity problems, adverse reac-
tions, or infection (Table 5). However, these recommenda-
tions are only guidelines, and without adverse reactions or
infection, alginates, films, foams, hydrogels, and hydrocol-
loids may remain on the wound bed longer than 7 days.209
The integrity and physical properties of a dressing will
influence performance and healing outcomes. Wrinkling or
bunching of the dressing and the formation of channels
from the wound bed to the edge, separation of the dressing
edges from the periwound tissues, or excessive accumula-
tion of exudate leading to strike-through can result in
leakage of exudate.89,91,94 Leakage of exudate and failure of
the dressing to maintain a barrier to the external
environment can increase the risk of cross-contamination
and infection and may lead to wound desiccation.89,166,167
Dressing transitions are also necessary as the wound
progresses through the phases of healing.§ No one dressing
is appropriate for every wound,210,211 and few dressings are
suited for treating a single wound throughout the healing
process.100 Dressing transitions may be required as healing
progresses, based on cellular and chemical changes in the
wound bed, such as decreasing levels of exudate and new
epithelial growth.100 Dressings that become saturated with
exudate in the early phases of healing may require
additional changes to lessen the risk of leakage and
maceration.91,168 Reductions in exudate levels as healing
progresses indicate the need for a change to a dressing that
is less absorbent or has a lower moisture vapor transmission
rate to maintain sufficient moisture over the wound
bed.91,94,104 Dry wounds with minimal exudate may require
a moisture-donating dressing to prevent desiccation of the
wound bed.108
Several suggestions are provided to assist with clinical
application of wound dressings. Nonocclusive and occlu-
sive dressings are available in a variety of sizes to fit the
diameter of the wound, and most can be cut to obtain a
proper fit. Generally, the dressing should be 1 to 2 cm larger
than the wound bed to provide an adequate edge seal on the
periwound tissues.91,105,122,170 Most nonocclusive dressings
require a secondary dressing, whereas the majority of
occlusive dressings do not. Nonocclusive dressings can be
secured with adhesive gauze (eg, Cover-Roll; BSN Medical
Inc, Charlotte, NC; or Omnifix; Hartmann USA, Rock Hill,
SC) or nonadherent, self-adherent, or adherent tapes and
wraps. Adhesive gauze applied to the edges of films, foams,
and hydrogels and over the entire surface of alginates and
hydrocolloids effectively secures these dressings to patients
for practices and competitions.2,112 Dressing removal
should be approached with caution to avoid trauma to the
wound bed. Maintaining moisture over the wound bed
prevents occlusive dressings from adhering and protects
against damage to the tissue upon removal.105 Dressings
that are adhered to the wound bed should be moistened with
normal saline or tap water through irrigation before
removal.91 With minimal exudate over the wound, some
occlusive dressings (eg, films) can adhere to the wound bed
and require moistening for removal.105
Education for patients on wound dressings and the
recommended guidelines for wear is needed to ensure
compliance. Patients must be encouraged to follow the
directions provided by the athletic training staff for daily
monitoring and identifying the signs and symptoms of
infection and adverse reactions. Guidelines specific to
occlusive-dressing wear and length of time over the wound
bed should prevent unnecessary dressing changes. As a
moist environment is created, the collection of exudate will
be visible under transparent film and hydrogel dressings.
This brownish fluid should not be confused with infec-
tion.103 Alginates and hydrocolloids react with and absorb
exudate over the wound bed, producing a gel-like
mass.91,105,173 This gel can have a foul odor and should
not be mistaken for infection.91,105 Absorption of exudate
can cause swelling and expansion of occlusive dressings
over the wound bed. Direct forces from contact with
equipment, playing surfaces, and other individuals can
rupture the dressings or force exudate to the dressing edges,
resulting in the formation of channels and subsequent
leakage.
Supplies for Athletic Training Facilities and Kits
Athletic training facilities and kits should have supplies
for the management of acute skin trauma. Minimal supplies
are required for kits used during practices and competitions.
Timely cleansing, debridement, and dressing of wounds are
often necessary to return patients to activity as soon as
possible. Infection-control guidelines must be followed
when managing patients with acute skin trauma. The
Occupational Safety and Health Administration,212 Centers
for Disease Control and Prevention,213 National Athletic
Trainers’ Association,129 and National Collegiate Athletic
Association214 guidelines provide infection-control mea-
sures to implement in the management of acute wounds.
The measures include developing a written organizational
control plan; educating staff members regarding control
measures; promoting the cleansing and disinfecting of
tables, supplies, and laundry; ensuring hand-hygiene and
personal-hygiene practices among staff members and
patients; adhering to sport association recommendations;
and verifying documentation of recommended measures.
CONCLUSIONS
Certified ATs and other allied health and medical
professionals must be able to manage patients with acute
skin trauma to promote healing and lessen the risk of
complications. This position statement presents recommen-
dations to educate clinicians about cleansing, debridement,
and dressing techniques; recognition, management, and
prevention of infection and adverse reactions; and moni-
toring and educating the patient.
DISCLAIMER
The NATA and NATA Research & Education Founda-
tion publish position statements as a service to promote the
awareness of certain issues to their members. The
information contained in the position statement is neither
exhaustive nor exclusive to all circumstances or individu-
als. Variables such as institutional human resource
guidelines, state or federal statutes, rules, or regulations,
as well as regional environmental conditions, may impact
the relevance and implementation of those recommenda-§References 91, 94, 100, 104, 108, 168, 169.
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tions. The NATA and NATA Foundation advise members
and others to carefully and independently consider each of
the recommendations (including the applicability of same
to any particular circumstance or individual). The position
statement should not be relied upon as an independent basis
for care but rather as a resource available to NATA
members or others. Moreover, no opinion is expressed
herein regarding the quality of care that adheres to or
differs from the NATA and NATA Foundation position
statements. The NATA and NATA Foundation reserve the
right to rescind or modify its position statements at any
time.
This position statement is primarily intended to present
acute wound care in the context of clinical practice in the
United States. However, many sections are applicable to
international clinical practice as well.
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